Search

everythinglearnresearchcommunity

for

Search:↓

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

COVID-19 can cause skin problems in children.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The treatment might help COVID-19 related hair loss, but more research is needed.

COVID-19 can cause hair loss and nail changes in some patients.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

Kampo medicine can help treat general fatigue from long COVID.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Researchers developed a new method to test hair growth drugs and found that adult cells are best for hair growth, but the method needs improvement as it didn't create mature hair follicles.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Ringworm of the body and scalp is treated with antifungal creams and oral medication, and children with scalp ringworm don't need to miss school.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Long COVID affects many body systems and needs careful management.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.